Sartorius Accessia Pharma
The computed 12-month bankruptcy probability of Sartorius Accessia Pharma is 0.7% (low). The company has been active since 2016 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 10 yrs |
| Locations | 1 |
| Publications | 14 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | volledig | 13-04-2026 | 2026-00077882 |
| 31-12-2024 | volledig | 09-04-2025 | 2025-00068326 |
| 31-12-2023 | volledig | 29-05-2024 | 2024-00099693 |
| 31-12-2022 | volledig | 26-05-2023 | 2023-00095228 |
| 31-12-2021 | volledig | 10-08-2022 | 2022-20283644 |
| 31-12-2020 | volledig | 12-04-2021 | 2021-10200452 |
| 31-12-2019 | volledig | 24-06-2020 | 2020-20900112 |
| 31-12-2018 | volledig | 19-03-2019 | 2019-07600595 |
| 31-12-2017 | volledig | 25-04-2018 | 2018-10700436 |
| NACE primary | Renting & leasing(77399) |
| Legal form | Public limited company(014) |
| Incorporation | 22-03-2016 |
| Status | Active |
| Postal code | 4041 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62064A0220/00G000 | Wallonia | 8,511 m² | 1 · 1,406 m² | 12.8 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
28-01-2025 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "Sartorius Accessia Pharma",
"old": "ACCESSIA PHARMA",
"changed": true
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0650.670.852",
"name_full": "ACCESSIA PHARMA"
},
"legal_form_change": {
"new": "Soci\u00E9t\u00E9 anonyme",
"old": "Soci\u00E9t\u00E9 anonyme",
"changed": false
}
}25-04-2024 3 directors appointed, 2 resigning
- Jonas Skjødt MOLLER, Bestuurder
- Franck BACKERS, Bestuurder
- Franck BACKERS, Gedelegeerd bestuurder
- MPH SRL, Gedelegeerd bestuurder
- MDT Services & Technologies SRL, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Jonas Skj\u00F8dt MOLLER",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Franck BACKERS",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Franck BACKERS",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "MPH SRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "MDT Services \u0026 Technologies SRL",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0650.670.852",
"name_full": "ACCESSIA PHARMA"
}
}11-04-2023 4 directors appointed
- MDT SERVICES & TECHNOLOGIES, Bestuurder
- MPH, Bestuurder
- MDT SERVICES & TECHNOLOGIES, Gedelegeerd bestuurder
- MPH, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "MDT SERVICES \u0026 TECHNOLOGIES",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "MPH",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "MDT SERVICES \u0026 TECHNOLOGIES",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "MPH",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0650.670.852",
"name_full": "ACCESSIA PHARMA"
}
}30-12-2022 2 directors appointed, 4 resigning
- MPH SRL, Bestuurder
- MDT Services & Technologies, Personne déléguée à la gestion journalière
- Xpress Biologics SA, Bestuurder
- MDT Services & Technologies, Bestuurder
- Xpress Biologics SA, Personne déléguée à la gestion journalière
- MDT Services & Technologies, Personne déléguée à la gestion journalière
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Xpress Biologics SA",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "MDT Services \u0026 Technologies",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "MPH SRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "personne d\u00E9l\u00E9gu\u00E9e \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "Xpress Biologics SA",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "personne d\u00E9l\u00E9gu\u00E9e \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "MDT Services \u0026 Technologies",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "personne d\u00E9l\u00E9gu\u00E9e \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "MDT Services \u0026 Technologies",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0650.670.852",
"name_full": "ACCESSIA PHARMA"
}
}30-09-2022 1 director appointed, 1 resigning
- Mazars Réviseurs d'Entreprises SRL, Auditor
- Deloitte Bedrijfsreviscren/Réviseurs d'Entreprises BV/SRL, Auditor
Technical details
{
"events": [
{
"kind": "director_out",
"role": "auditor",
"person": {
"rrn": null,
"name": "Deloitte Bedrijfsreviscren/R\u00E9viseurs d\u0027Entreprises BV/SRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "auditor",
"person": {
"rrn": null,
"name": "Mazars R\u00E9viseurs d\u0027Entreprises SRL",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0650.670.852",
"name_full": "ACCESSIA PHARMA"
}
}27-07-2022 5 directors appointed, 6 resigning
- MDT SERVICES & TECHNOLOGIES, Bestuurder
- XPRESS BIOLOGICS, Bestuurder
- MDT SERVICES & TECHNOLOGIES, Gedelegeerd bestuurder
- XPRESS BIOLOGICS, Gedelegeerd bestuurder
- Franck BACKERS, Cfo
- SMAL Jean, Bestuurder
- SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT, Bestuurder
- NOSHAQ, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "SMAL Jean",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "SOCIETE FEDERALE DE PARTICIPATIONS ET D\u0027INVESTISSEMENT",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "NOSHAQ",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Monument Immo Management",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "SAMANDA",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "MDT SERVICES \u0026 TECHNOLOGIES",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "XPRESS BIOLOGICS",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Leap Consulting",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "MDT SERVICES \u0026 TECHNOLOGIES",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "XPRESS BIOLOGICS",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "CFO",
"person": {
"rrn": null,
"name": "Franck BACKERS",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0650.670.852",
"name_full": "ACCESSIA PHARMA"
}
}19-07-2022 3 directors appointed, 2 resigning
- Marie Braun, Bestuurder
- Leap Consulting SPRL, Dagelijks bestuur
- Benjamin Boinem, Dagelijks bestuur
- Marc Foidart, Bestuurder
- Mr. Verjans, Dagelijks bestuur
Technical details
{
"events": [
{
"kind": "director_in",
"role": "Administrateur",
"person": {
"rrn": null,
"name": "Marie Braun",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "Administrateur",
"person": {
"rrn": null,
"name": "Marc Foidart",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "D\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "Leap Consulting SPRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "D\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "Benjamin Boinem",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "D\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "Mr. Verjans",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0650.670.852",
"name_full": "ACCESSIA PHARMA"
}
}11-05-2022 Capital decrease of €2,600,000 to €7,400,000
- €10.000.000 → €7.400.000
Technical details
{
"events": [
{
"kind": "capital_decrease",
"after_eur": 7400000,
"delta_eur": -2600000,
"before_eur": 10000000,
"contribution_type": null
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0650.670.852",
"name_full": "ACCESSIA PHARMA"
}
}30-04-2021 Julie Delforge appointed as commissaire aux comptes
- Julie Delforge, Commissaire aux comptes
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaire aux comptes",
"person": {
"rrn": null,
"name": "Julie Delforge",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0650.670.852",
"name_full": "ACCESSIA PHARMA"
}
}03-11-2020 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0650.670.852",
"name_full": "ACCESSIA PHARMA"
},
"legal_form_change": {
"new": "Soci\u00E9t\u00E9 anonyme",
"old": "Soci\u00E9t\u00E9 anonyme",
"changed": false
}
}25-02-2019 1 director appointed, 1 resigning
- FRANSSEN Christina, Representant permanent
- BASTIN David, Representant permanent
Technical details
{
"events": [
{
"kind": "director_in",
"role": "representant permanent",
"person": {
"rrn": null,
"name": "FRANSSEN Christina",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "representant permanent",
"person": {
"rrn": null,
"name": "BASTIN David",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0650.670.852",
"name_full": "ACCESSIA PHARMA"
}
}22-03-2017 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "ACCESSIA PHARMA",
"old": "ACCESSIA GMP",
"changed": true
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0650.670.852",
"name_full": "ACCESSIA GMP"
},
"legal_form_change": {
"new": "Soci\u00E9t\u00E9 anonyme",
"old": "Soci\u00E9t\u00E9 anonyme",
"changed": false
}
}14-11-2016 Capital increase of €1,000,000 to €4,000,000
- €3.000.000 → €4.000.000
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 4000000,
"delta_eur": 1000000,
"before_eur": 3000000,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0650.670.852",
"name_full": "ACCESSIA GMP"
}
}24-03-2016 Incorporation of a new SA
Technical details
{
"notary": {
"name": "Jean-Michel Gauthy",
"firm_city": null,
"firm_name": "Gauthy \u0026 Jacques \u2013 Notaires Associ\u00E9s",
"office_city": "Li\u00E8ge",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2016-03-24",
"filing_date": "2016-03-22",
"act_kind_objet": "Objet de l\u0027acte:",
"is_private_deed": false
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2016-03-22",
"unanimous": true
},
"founders": [
{
"org": {
"kbo": "0877.938.090",
"name": "SOFIP\u00D4LE SA",
"address": "4000 Li\u00E8ge, avenue Maurice Destenay, 13",
"country": "BE",
"legal_form": "SA",
"foreign_register_name": null,
"foreign_register_number": null
},
"kind": "rechtspersoon",
"person": null,
"share_class": null,
"partner_role": null,
"contribution_type": "geld",
"amount_paid_in_eur": 1000000.0,
"is_subscriber_only": false,
"n_shares_subscribed": 1000,
"amount_subscribed_eur": 1000000.0,
"is_anonymous_silent_partner": false
},
{
"org": {
"kbo": "0474.379.686",
"name": "INTEGRALE IMMO MANAGEMENT SA",
"address": "4000 Li\u00E8ge, Place Saint-Jacques, 11, bo\u00EEte 103",
"country": "BE",
"legal_form": "SA",
"foreign_register_name": null,
"foreign_register_number": null
},
"kind": "rechtspersoon",
"person": null,
"share_class": null,
"partner_role": null,
"contribution_type": "geld",
"amount_paid_in_eur": 1000000.0,
"is_subscriber_only": false,
"n_shares_subscribed": 1000,
"amount_subscribed_eur": 1000000.0,
"is_anonymous_silent_partner": false
},
{
"org": {
"kbo": "0426.624.509",
"name": "SOCI\u00C9T\u00C9 DE D\u00C9VELOPPEMENT ET DE PARTICIPATION DU BASSIN DE LI\u00C8GE",
"address": "4000 Li\u00E8ge, H\u00F4tel de Copis, rue Lambert Lombard 3",
"country": "BE",
"legal_form": "SA",
"foreign_register_name": null,
"foreign_register_number": null
},
"kind": "rechtspersoon",
"person": null,
"share_class": null,
"partner_role": null,
"contribution_type": "geld",
"amount_paid_in_eur": 1000000.0,
"is_subscriber_only": false,
"n_shares_subscribed": 1000,
"amount_subscribed_eur": 1000000.0,
"is_anonymous_silent_partner": false
}
],
"voorwerp": {
"full_text": "La soci\u00E9t\u00E9 a pour objet principal de construire, installer, \u00E9quiper, valider, faire approuver par les autorit\u00E9s comp\u00E9tentes, g\u00E9rer et maintenir des sites de R\u0026D et de production GMP pour des soci\u00E9t\u00E9s actives dans le secteur de la sant\u00E9 (pharmaceutique, biotechnologique, medical device, diagnostique et autres activit\u00E9s similaires). La soci\u00E9t\u00E9 offrira des salles blanches, des laboratoires, des bureaux, des zones de stockage dans diff\u00E9rentes conditions et toute autre structure qui pourrait \u00EAtre utile dans le cadre de son activit\u00E9 et de l\u2019activit\u00E9 de ses clients. La soci\u00E9t\u00E9 sera \u00E9galement active dans l\u2019offre de services autour de son activit\u00E9 principale, ce qui comprend mais n\u2019est pas limit\u00E9 \u00E0 : un support en terme de qualit\u00E9 (contr\u00F4le de qualit\u00E9 et assurance de qualit\u00E9), l\u2019achat et l\u2019installation d\u2019\u00E9quipements de production et de recherche, l\u2019offre de service de maintenance d\u2019\u00E9quipement de production, la mise \u00E0 disposition de personnel de production, la lib\u00E9ration de lots de production.\n\nElle peut accomplir toutes op\u00E9rations g\u00E9n\u00E9ralement quelconques, commerciales, industrielles, financi\u00E8res, mobili\u00E8res ou immobili\u00E8res, se rapportant directement ou indirectement \u00E0 son objet.\n\nLa soci\u00E9t\u00E9 peut s\u0027int\u00E9resser par toutes voies dans toutes affaires, entreprises ou soci\u00E9t\u00E9s ayant un objet identique, similaire ou connexe, ou qui sont de nature \u00E0 favoriser le d\u00E9veloppement de son entreprise, \u00E0 lui procurer des mati\u00E8res premi\u00E8res ou \u00E0 faciliter l\u0027\u00E9coulement de ses produits.",
"is_lucrative": true,
"short_summary": "Construction, installation, equipment, management, and maintenance of GMP R\u0026D and production sites for health sector companies, including clean rooms, laboratories, offices, storage areas, and related services."
},
"governance": {
"organ_kind": "raad_van_bestuur",
"n_directors_max": 5,
"n_directors_min": 1,
"representation_clause": "twee bestuurders",
"co_signature_threshold_eur": null
},
"fiscal_year": {
"end_mm_dd": "12-31",
"start_mm_dd": "01-01",
"first_exercise_end_date": "2017-12-31",
"is_prolonged_first_exercise": false
},
"agm_schedule": {
"time": "10:00",
"month": 3,
"rule_text": "deuxi\u00E8me vendredi du mois de mars"
},
"founding_event": {
"n_shares_total": 3000,
"n_share_classes": 1,
"bank_attestation": {
"date": "2016-03-22",
"bank_name": "KBC",
"amount_eur": 3000000.0,
"iban_masked": "BE43 3632 6778 4001"
},
"amount_paid_in_eur": 3000000.0,
"incorporation_date": "2016-03-22",
"amount_subscribed_eur": 3000000.0,
"art_5_8_no_payment_due": false,
"pre_incorporation_activity_from_date": "2015-11-01"
},
"subject_company": {
"kbo": "0650.670.852",
"email": null,
"region": "waals_gewest",
"website": null,
"name_full": "ACCESSIA GMP",
"legal_form": "SA",
"name_abbreviated": "ACCESSIA GMP",
"zetel_address_raw": "4000 Li\u00E8ge, H\u00F4tel de Copis, rue Lambert Lombard 3",
"equity_account_type": "available",
"_kbo_extracted_mismatch": "0877.938.090"
},
"initial_directors": [
{
"kind": "rechtspersoon",
"person": {
"name": "SAMANDA",
"address": "4000 Li\u00E8ge, avenue Maurice Destenay, 13"
},
"via_org": {
"kbo": "0877.938.090",
"name": "SOFIP\u00D4LE SA",
"legal_form": "SA"
},
"role_sub": "bestuurder",
"mandate_until": {
"kind": "until_agm_year",
"value": 2022
},
"rep_person_name": "David Bastin",
"additional_roles": [],
"bestuursverbod_checked": false,
"bestuursverbod_check_date": null,
"rep_prior_publication_ref": {
"date": "2016-03-22",
"numac_or_number": "16029444"
}
},
{
"kind": "rechtspersoon",
"person": {
"name": "INTEGRALE IMMO MANAGEMENT SA",
"address": "4000 Li\u00E8ge, Place Saint-Jacques, 11, bo\u00EEte 103"
},
"via_org": {
"kbo": "0474.379.686",
"name": "INTEGRALE IMMO MANAGEMENT SA",
"legal_form": "SA"
},
"role_sub": "bestuurder",
"mandate_until": {
"kind": "until_agm_year",
"value": 2022
},
"rep_person_name": "C\u00E9dric Sacr\u00E9",
"additional_roles": [],
"bestuursverbod_checked": false,
"bestuursverbod_check_date": null,
"rep_prior_publication_ref": {
"date": "2016-03-22",
"numac_or_number": "16029444"
}
},
{
"kind": "rechtspersoon",
"person": {
"name": "MEUSINVEST SA",
"address": "4000 Li\u00E8ge, H\u00F4tel de Copis, rue Lambert Lombard 3"
},
"via_org": {
"kbo": "0426.624.509",
"name": "MEUSINVEST SA",
"legal_form": "SA"
},
"role_sub": "bestuurder",
"mandate_until": {
"kind": "until_agm_year",
"value": 2022
},
"rep_person_name": "Marc Foidart",
"additional_roles": [],
"bestuursverbod_checked": false,
"bestuursverbod_check_date": null,
"rep_prior_publication_ref": {
"date": "2016-03-22",
"numac_or_number": "16029444"
}
},
{
"kind": "natural_person",
"person": {
"name": "Jean Smal",
"address": "1030 Bruxelles, avenue de l\u2019Opale, 106"
},
"via_org": null,
"role_sub": "bestuurder",
"mandate_until": {
"kind": "until_agm_year",
"value": 2022
},
"rep_person_name": null,
"additional_roles": [],
"bestuursverbod_checked": false,
"bestuursverbod_check_date": null,
"rep_prior_publication_ref": null
},
{
"kind": "natural_person",
"person": {
"name": "Beno\u00EEt Verjans",
"address": "1050 Bruxelles, rue de la Natation 30M"
},
"via_org": null,
"role_sub": "directeur_general",
"mandate_until": {
"kind": "indefinite",
"value": null
},
"rep_person_name": null,
"additional_roles": [],
"bestuursverbod_checked": false,
"bestuursverbod_check_date": null,
"rep_prior_publication_ref": null
}
],
"co_filed_documents": [
"expedition",
"statuten",
"volmacht",
"plan financier",
"bankattest"
],
"post_incorporation_mandates": [
{
"kind": "volmacht_kbo",
"holder_org_kbo": "0877.938.090",
"holder_org_name": "Gauthy \u0026 Jacques \u2013 Notaires Associ\u00E9s",
"with_substitution": false,
"holder_person_name": null
}
]
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | Sartorius Accessia Pharma |